J. Linnehan

Histidines 13 and 14 in the Aβ sequence are targets for inhibition of Alzheimer's disease Aβ ion channel and cytotoxicity

H. Pollard, J. Díaz, J. Linnehan, 2006 .

Clinical, safety, and economic evidence in radioactive iodine-refractory differentiated thyroid cancer: a systematic literature review.

Roger. T. Anderson, L. Wirth, J. Linnehan, 2013, Thyroid : official journal of the American Thyroid Association.

Economic analysis of decitabine versus best supportive care in the treatment of intermediate- and high-risk myelodysplastic syndromes from a US payer perspective.

K. Knopf, R. Fleurence, J. Linnehan, 2010, Clinical therapeutics.

Budgetary Impact on a U.S. Health Plan Adopting Abiraterone Acetate Plus Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer

S. Sorensen, J. Linnehan, V. Hutchins, 2013, Journal of managed care pharmacy : JMCP.

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective

S. Connolly, S. Sorensen, J. Plumb, 2011, Thrombosis and Haemostasis.

Histidines 13 and 14 in the Abeta sequence are targets for inhibition of Alzheimer's disease Abeta ion channel and cytotoxicity.

H. Pollard, J. Díaz, J. Linnehan, 2006, Biological Research.